Registered Kenya · PPB

SURDEX SYRUP

PHENYLEPRINEHYDROCHLORIDEPARACETAMOLCHLORPHENERAMINE MALEATE

H2011/22063/085 PHENYLEPRINEHYDROCHLORIDE 2.5MGPARACETAMOL 125MGCHLORPHENERAMINE MALEATE 1.0MG

What it does

This medicine combines three active ingredients to relieve symptoms such as pain, fever, and allergy reactions.

Commonly used for: pain relief (analgesia), fever reduction (antipyretic), allergy symptoms (hay fever) relief

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2011/22063/085
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
PHENYLEPRINEHYDROCHLORIDEPARACETAMOLCHLORPHENERAMINE MALEATE
Dosage form
PHENYLEPRINEHYDROCHLORIDE 2.5MGPARACETAMOL 125MGCHLORPHENERAMINE MALEATE 1.0MG
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Theralife Pharma
Applicant / LTR
-
Country of origin
FOREIGN

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:10:08 · updated 2026-03-23 04:55:19

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

This medicine combines three active ingredients to relieve symptoms such as pain, fever, and allergy reactions.

What it treats

  • pain relief (analgesia)
  • fever reduction (antipyretic)
  • allergy symptoms (hay fever) relief

How it works

It works by blocking certain chemicals in the body that cause pain and allergic reactions, while also reducing fever.

Who it's for

This medicine is for adults and children experiencing pain, fever, or allergy symptoms.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: phenyleprinehydrochlorideparacetamolchlorpheneramine

Contra-indications

  • Hypersensitivity to phenylephrine, paracetamol, chlorpheniramine or any component of the formulation
  • Severe hypertension
  • Severe coronary artery disease
  • Concurrent use of monoamine oxidase inhibitors (MAOIs)

Adverse effects

  • Dizziness
  • Headache
  • Nausea
  • Vomiting
  • Dry mouth
  • Constipation
  • Drowsiness
  • Blurred vision
  • Increased blood pressure
  • Palpitations

Interactions

  • Caution with other sympathomimetic drugs
  • Increased risk of adverse effects with alcohol
  • Potential interaction with antihypertensive agents
  • MAOIs can cause hypertensive crisis when used with sympathomimetics

Precautions

  • Use with caution in patients with hypertension, diabetes, hyperthyroidism or prostatic hypertrophy
  • Patients should be monitored for signs of increased blood pressure
  • Use with caution in elderly patients

Pregnancy

Use during pregnancy is not recommended unless clearly necessary. Consult healthcare professionals for advice.

Breast-feeding

Paracetamol is generally considered safe during breastfeeding. Caution is advised with chlorpheniramine due to its sedative effects.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Tablets
  • Syrups
  • Suspensions
PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.